Dave Heldman

Dave Heldman is a seasoned professional in the field of innovation and diagnostics, currently serving as the Director of Innovation at Danaher Corporation since October 2021. Prior to this role, significant experience was accumulated at Beckman Coulter Diagnostics from November 2007 to October 2021, where multiple senior management positions were held, focusing on innovation, continuous improvement, and reagent development. Earlier career achievements include a position as Research and Development Specialist at DiaSorin Inc from June 2004 to October 2007. Dave Heldman holds a Master's degree in Biological Science, specializing in Immunology, Biochemistry, and Public Health from the University of Minnesota, obtained between 2008 and 2013, as well as a Bachelor of Arts degree in Immunology, Microbiology, and Biochemistry from Gustavus Adolphus College, completed in May 2004.